Portfolio company
Astrivax
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops thermostable vaccines and immunotherapies to prevent or treat infectious diseases and virus-driven cancers for patients worldwide.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bactheravax
This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.
Alzinova
This biopharmaceutical company develops immunotherapies and vaccines targeting toxic amyloid-beta oligomers to treat and prevent Alzheimer's disease for patients worldwide.
Centivax
This company develops broad-spectrum vaccines and monoclonal antibodies using computational immune engineering to protect against infectious diseases and pathogens for global healthcare systems.
Baseimmune
The company develops AI-designed vaccines and antigens for pharmaceutical partners and biotech researchers to treat infectious diseases and chronic conditions in humans and animals.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Stratosvir
This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.
Vaccitech Ltd
This biopharmaceutical company develops immunotherapeutic products and vaccines for patients with chronic infectious diseases, autoimmune conditions and cancer.
Aerium Therapeutics
This biopharmaceutical company develops monoclonal antibodies and antiviral treatments to protect immunocompromised patients against COVID-19 and future epidemic threats.
